At 1 month , continuous abstinence from smoking was reported for 40 % of participants receiving cytisine ( 264 of 655 ) and 31 % of participants receiving nicotine-replacement therapy ( 203 of 655 ) , for a difference of 9.3 percentage points ( 95 % confidence interval , 4.2 to 14.5 ) .